#192 Alguien tiene que pagar a las farmaceuticas y cirujanos que hacen los procedimientos y fabrican las hormonas que teneis que tomar toda la vida. En España es la Seguridad Social, pero en sistemas con sanidad privada son los clientes. Y sobre el auge de esta no-enfermedad, te dejo algunos articulos:
Sweden’s Board of Health and Welfare which confirmed a 1,500% rise between 2008 and 2018 in gender dysphoria diagnoses among 13- to 17-year-olds born as girls.
But it also reflects a rapid change in public opinion. Just a year ago, there seemed few official obstacles left in the way of young people who wanted gender reassignment treatment.
In the autumn of 2018, the Social Democrat-led government, under pressure from the gay, lesbian and transgender group RFSL, proposed a new law which would reduce the minimum age for sex reassignment medical care from 18 to 15, remove all need for parental consent, and allow children as young as 12 to change their legal gender.
The study is an analysis of a 2016 statewide survey of almost 81,000 Minnesota teens.
Nearly 2,200 identified as transgender or gender nonconforming. The study found that these kids reported worse mental and physical health than other kids, echoing results seen in previous research. Bullying and discrimination are among possible reasons for the differences, Rider said, although the survey didn’t ask.
[...]
Although the study only included teens in two grades, the rates are higher than a UCLA study released last year estimating that 0.7 percent of teens aged 13 to 17 are transgender, or about 150,000 kids. That study used government data on adults to estimate numbers for children. It said 0.6 percent of U.S. adults identify as transgender, or about 1.4 million.
Y de extra, las personas trans post operación tienden a ser menos felices y estables psicologicamente que la población normal.
Although further robust longitudinal studies are needed, current evidence [...] indicates that those having undergone sex reassignment have significantly higher risk for mortality (3 times more likely), suicidality (5 times more likely), death by suicide (19 times more likely), and psychiatric morbidity (3 times more likely) than matched controls in the general population. Figure 1 shows the trends over a 30-year follow-up period. Negative outcomes were greater for MTF compared with FTM individuals.
Mental health was considerably more impaired in the transgender population compared with male and female reference groups (Quinn et al., 2017). For example, anxiety was diagnosed in 38% of trans females (TF) compared with 22% of reference females (RF). Depression was diagnosed in 49% (TF) vs 25% (RF); suicidal ideation in 5% (TF) compared with 0.6% (RF); and substance abuse disorder in 15% TF compared with 5% RF. In trans males (TM) mental health was significantly worse compared with reference males (RM). For example, 46% TM were diagnosed with anxiety compared with 13% RM. Similarly, for depression (55% vs13%), self-inflicted injury (4.2% vs 0.4%), suicidal ideation (6.7% vs 0.6%), and substance abuse disorder (14% vs 8.4%), TM were significantly more disadvantaged than RM.
#193 De verdad que comparar una masectomia, histeroctomia u operación de conversión de un glande en neovagina con hacerse agujeros en la orejas no me parece comparable en absolutamente nada.
Pero te doy la razón en que ambas son soluciones que lo unico de lo que tratan es de amoldar a personas a las categorias normativas del genero. Y por tanto, no combaten lo realmente negativo, que existan dichas categorias.